Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Section Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
J Control Release. 2019 Jan 10;293:126-134. doi: 10.1016/j.jconrel.2018.11.020. Epub 2018 Nov 25.
Cyclodextrin (CD)-based supramolecular interactions have been proposed as nanocarriers for drug delivery. We previously explored the use of these supramolecular interactions to perform targeted hepatic radioembolization. In a two-step procedure the appropriate location of the diagnostic pre-targeting vector can first be confirmed, after which the therapeutic vector will be targeted through multivalent host-guest interactions. Such a procedure would prevent therapeutic errors that come from a mismatch between diagnostic and therapeutic procedures. In the current study we explored the use of dual-isotope imaging to assess the in vivo stability of the formed complex and individual components.
Dual-isotope imaging of the host and guest vectors was performed after labeling of the pre-targeted guest vector, being adamantane (Ad) functionalized macro-aggregated albumin (MAA) particles, with technetium-99 m (Tc-MAA-Ad). The host vector, Cy5CDPIBMA, was labeled with indium-111 (In-Cy5CDPIBMA). The in situ stability of both the individual vectors and the resulting [MAA-Ad-In-Cy5CDPIBMA] complexes was studied over 44 h at 37 °C in a serum protein-containing buffer. In vivo, the host vector In-Cy5CDPIBMA was administered two hours after local deposition of Tc-MAA-Ad in mice. Dual-isotope SPECT imaging and quantitative biodistribution studies were performed between 2 and 44 h post intravenous host vector administration.
The individual vectors portrayed <5% dissociation of the radioisotope over the course of 20 h. Dissociation of [MAA-Ad-In-Cy5CDPIBMA] complexes remained within a 10-20% range after incubation in serum. In vivo dual-isotope SPECT imaging of host-guest interactions revealed co-localization of the tracer components. Quantitative assessment of the biodistribution revealed that the hepatic accumulation of the host vector nearly doubled between 2 h and 44 h post-injection (from 14.9 ± 6.1%ID/g to 26.2 ± 2.1%ID/g).
Assessment of intra-hepatic host-guest complexation was successfully achieved using dual isotope multiplexing, underlining the complex stability that was found in situ (up to 44 h in serum). Overall, the results obtained in this study highlight the potential of supramolecular chemistry as a versatile platform that could advance the field of nanomedicine.
环糊精(CD)基超分子相互作用已被提议作为药物传递的纳米载体。我们之前探索了使用这些超分子相互作用进行靶向肝动脉栓塞治疗。在两步法中,可以首先确认诊断前靶向载体的适当位置,然后通过多价主体-客体相互作用靶向治疗载体。这样的程序将防止由于诊断和治疗程序之间不匹配而导致的治疗错误。在目前的研究中,我们探索了使用双同位素成像来评估形成的复合物和各个组件的体内稳定性。
在用锝-99m(Tc-MAA-Ad)标记预靶向的客体载体,即金刚烷(Ad)功能化的大聚集白蛋白(MAA)颗粒后,对客体和主体载体进行双同位素成像。主体载体 Cy5CDPIBMA 用铟-111(In-Cy5CDPIBMA)标记。在含有血清蛋白的缓冲液中,在 37°C 下,将单独的载体和形成的 [MAA-Ad-In-Cy5CDPIBMA] 复合物的稳定性研究了 44 小时。在体内,Tc-MAA-Ad 局部沉积后两小时,给予主体载体 In-Cy5CDPIBMA。在静脉内给予主体载体后 2 至 44 小时,进行双同位素 SPECT 成像和定量生物分布研究。
单独的载体在 20 小时内放射性同位素的解离率<5%。在血清孵育后,[MAA-Ad-In-Cy5CDPIBMA] 复合物的解离率仍保持在 10-20%范围内。体内双同位素 SPECT 成像显示示踪剂成分的共定位。定量生物分布评估显示,在注射后 2 小时至 44 小时之间,主体载体在肝脏中的积累几乎增加了一倍(从 14.9±6.1%ID/g 增加到 26.2±2.1%ID/g)。
使用双同位素多路复用成功评估了肝内主体-客体络合,强调了原位(在血清中长达 44 小时)发现的复合物稳定性。总的来说,本研究的结果突出了超分子化学作为一个多功能平台的潜力,该平台可能会推进纳米医学领域的发展。